Collaborations
We interact with our research partners through a variety of funding mechanisms:
SBIR/STTR Grants
- 16-20% Phase I funding rate
- 40% conversion rate to Phase II
- Inaccessible to Academia
R01/U01 Grants
- FCCDC acts as a sub-contractor
- We write medicinal chemistry part of grant application
Fee-for-Service
- Useful to obtain preliminary or advanced data for grant submissions to afford a higher probability of success
FTE Sponsored Research
- Extensive interaction and brainstorming
- Flexibility
- Guaranteed capacity
Current Collaborators
- Portage Biotech Inc. and Biohaven
- The Wistar Institute
- Vironika LLC
- ALS Biopharma
- University of Pennsylvania
- University of Pittsburgh
- New York Blood Center
- Rutgers University
- University of Florida
- Thomas Jefferson University
- Temple University
- University of Arizona
- Albert Einstein University